Hepcludex (bulevirtide-gmod) Coverage for Chronic Hepatitis Delta Virus Infection
Customize your policy alerts
Sign up for Empire Bluecross Policy CC-0303 alerts
Get alerted when Policy CC-0303 changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and medical necessity review for Hepcludex (bulevirtide-gmod) used to treat chronic hepatitis delta virus infection in adults. It applies to providers requesting initial or continuation coverage under the member's applicable benefit.
A new clinical criteria document was added for Hepcludex (bulevirtide-gmod).
HCPCS codes C9399 and J3590 and ICD-10-CM code B18.0 were added for Hepcludex-related coding.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.